First AD

Second AD

Multiple Myeloma

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Sundar Jagannath, MD

OncLive News Network®

Emerging Combinations for Relapsed/Refractory Multiple Myeloma

Monitoring Response and Defining Complete Remission in Multiple Myeloma

Maximizing Stem Cell Transplantation in Multiple Myeloma

Maintenance Therapy Improves Outcomes in Multiple Myeloma

Treating Newly Diagnosed Multiple Myeloma